Gossypol
- Generic Name
- Gossypol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H30O8
- CAS Number
- 303-45-7
- Unique Ingredient Identifier
- KAV15B369O
- Background
Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 204
- Registration Number
- NCT01977209
- Locations
- 🇨🇳
Chongqing Zhongshan Hospital, Chongqing, Chongqing, China
🇨🇳Jiangjin Central Hospital, Chongqing, Chongqing, China
🇨🇳Three Gorges Central Hospital, Chongqing, Chongqing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath